![]() |
Volumn 7, Issue 1, 2011, Pages 7-9
|
Genetic testing in Parkinson diseaseg-who should be assessed?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA SYNUCLEIN;
DJ 1 PROTEIN;
LEUCINE RICH REPEAT KINASE 2;
MEMBRANE PROTEIN;
PARKIN;
PROTEIN GBA;
PROTEIN PINK1;
UNCLASSIFIED DRUG;
ETHNICITY;
GENE DOSAGE;
GENE MUTATION;
GENE SEQUENCE;
GENETIC ANALYSIS;
GENETIC ASSOCIATION;
GENETIC COUNSELING;
GENETIC SCREENING;
HEALTH PERSONNEL ATTITUDE;
HUMAN;
NEUROPROTECTION;
PARKINSON DISEASE;
PATIENT ATTITUDE;
PHENOTYPE;
PRIORITY JOURNAL;
REVIEW;
GENETICS;
MUTATION;
NOTE;
PRACTICE GUIDELINE;
GENETIC TESTING;
HUMANS;
MUTATION;
PARKINSON DISEASE;
PRACTICE GUIDELINES AS TOPIC;
|
EID: 78651375860
PISSN: 17594758
EISSN: 17594766
Source Type: Journal
DOI: 10.1038/nrneurol.2010.197 Document Type: Review |
Times cited : (6)
|
References (9)
|